Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,022 INR | +0.57% | -3.38% | +19.62% |
05-03 | Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer | CI |
04-29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.62% | 3.43B | |
+20.83% | 43.57B | |
+22.27% | 22.7B | |
+16.41% | 14.32B | |
+11.11% | 13.42B | |
+45.91% | 11.83B | |
-6.86% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.51B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Transcript : Glenmark Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 15, 2023